The research was motivated by a persistent frustration in psychiatry: the effectiveness of psychopharmaceutical treatments has largely stagnated in recent decades, and clinicians still have no reliable method for predicting which class of antidepressant, for example, will help a specific patient. The authors argue that the first step toward truly individualized treatment is the ability to predict psychological attributes from biological markers. If brain morphology can forecast cognitive performance at the individual level, the same logic could eventually extend to predicting treatment outcomes, closing a gap that group-level correlations between brain structure and behavior have never been able to bridge.

To capture as much structural information as possible, the team scanned 74 transdiagnostic patients and 41 healthy controls on a 7-Tesla Magnetom Terra scanner at Forschungszentrum Jülich, one of the most powerful clinical MRI systems available. The MP2RAGE sequence produced T1-weighted anatomical images at an isotropic resolution of 0.75 millimeters, far finer than the 1-millimeter standard of conventional 3-Tesla scanners. The patient group was genuinely heterogeneous: 49 participants had major depressive disorder, with the remainder diagnosed with schizophrenia, bipolar disorder, ADHD, alcohol or drug abuse disorders, and non-schizophrenic psychosis. Healthy controls were screened with the Mini International Neuropsychiatric Interview to exclude any lifetime neurological or psychiatric illness.

From each scan, the researchers extracted three families of morphological features: grey matter volume, cortical thickness, and gyrification, the degree of cortical folding. The brain was parcellated into 100 regions using the Schaefer Atlas, which defines areas according to functional connectivity patterns rather than anatomical landmarks alone. In total, 304 features fed into the model. The authors deliberately avoided any a priori hypotheses about which brain areas matter, adopting a strictly data-driven approach in which every atlas region contributed volumetric and surface parameters for every participant.

The classification model was a feed-forward neural network trained with a triple loss function, an objective well suited to small datasets because it embeds information in a compact latent space and carries a relatively low risk of overfitting. Participants were labeled as above- or below-median performers on the Trail-Making Test, with the A and B versions combined to double the number of data points per subject. Training ran for up to 200 epochs using the Adam optimizer with a learning rate of 0.2, a scheduler that reduced the rate when validation loss plateaued, and gradient clipping to stabilize updates. Crucially, the team employed a strict Leave-Subject-Out splitting scheme, ensuring that no individual’s data appeared in both training and validation sets during any iteration.

To guard against overly optimistic results, the entire pipeline was wrapped in an outer hold-out loop executed ten times with different random splits. The mean and median accuracy across all ten iterations was 0.795, with a standard deviation of only 0.068; the worst run scored 0.682 and the best 0.891. Validation loss tracked training loss closely, and accuracy reached a stable plateau by roughly epoch 30 to 40, indicating that the network learned generalizable patterns rather than memorizing noise. The low variance across independent runs was presented as key evidence that the model’s performance reflects true predictive power rather than a lucky data split.

Interpretability came from Shapley Additive Explanations, or SHAP, a technique that quantifies each feature’s contribution to the model’s output. Averaged across all ten hold-out iterations, the SHAP analysis revealed that gyrification was by far the most decisive feature, while cortical thickness did not appear among the important variables at all. Grey matter volume in frontal, parietal, temporal, and occipital regions also contributed meaningfully. The influential regions clustered within four functional networks: the sensorimotor network, the limbic network, the default mode network, and the dorsal attention network.

The anatomical pattern aligns remarkably well with decades of independent neuroscience. Gyrification changes in the sensorimotor network, including the auditory cortex, make intuitive sense because completing the Trail-Making Test requires fine motor coordination and speed control. The limbic contribution came from the left orbitofrontal cortex, a region known for temporal cognition, sequencing, and stimulus-reward processing. The default mode network was represented by the dorsal prefrontal cortex and temporal cortex, while the dorsal attention network contributed through the postcentral gyrus. Previous lesion-mapping studies have shown that damage to the dorsolateral prefrontal cortex and anterior cingulate cortex impairs Trail-Making performance, and functional imaging work has repeatedly implicated these same circuits, lending independent validation to the data-driven findings.

The dominance of gyrification carries a deeper biological message. Unlike grey matter volume and cortical thickness, which change measurably across adulthood in response to stress, aging, and disease, cortical folding is largely fixed during ontogenesis and early childhood development. The model’s heavy reliance on gyrification suggests that predisposing structural patterns shaping cognitive performance are set early in life, while the concurrent relevance of grey matter volume in temporal and parietal-occipital cortex shows that modifiable features still matter. This distinction between static and dynamic morphology may prove important for deciding which biomarkers are useful for tracking change over time versus characterizing stable individual traits.

Perhaps the most consequential implication concerns how psychiatric illness should be classified. A sizable proportion of both patients and controls fell on the slow side of the median test times, meaning that diagnosis alone was a poor predictor of cognitive function. The authors argue this supports a transdiagnostic approach, in which structural brain features, psychological test results, and demographic data inform clinical decisions rather than broad diagnostic categories. Notably, the model drew on the orbitofrontal cortex, a region more often associated with affective disease than with executive function, hinting that psychiatric conditions as different as bipolar disorder, unipolar depression, and the negative symptoms of schizophrenia may share overlapping neurobiological substrates. Symptom prediction from neuroimaging, the study concludes, appears to be an achievable goal, and establishing that brain structure can forecast cognitive performance is a crucial first step toward identifying which biological interventions are most likely to help each individual patient.

Subject of Research: Predicting cognitive test performance from 7-Tesla structural brain MRI using deep learning

Article Title: Predicting trail-making test performance using 7-Tesla structural cerebral MRI

Article References: Schnellbächer, G. J., Rajkumar, R., Veselinović, T., Ramkiran, S., Hagen, J., Collee, M., Shah, N. J., Neuner, I., & Dammers, J. (2026). Predicting trail-making test performance using 7-Tesla structural cerebral MRI. Translational Psychiatry, 16(1), Article 572. https://doi.org/10.1038/s41398-026-04402-x

Image Credits: AI Generated

DOI: 10.1038/s41398-026-04402-x

Keywords: 7-Tesla MRI, deep learning, Trail-Making Test, gyrification, grey matter volume, cortical thickness, transdiagnostic psychiatry, SHAP analysis, executive function, neuroimaging biomarkers, Translational Psychiatry, cognitive prediction